ReviewWorld journal of transplantation2015
Cardiovascular risk factors following renal transplant.
Review in World journal of transplantation, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06249477 (Weight Loss and Physical Activity Lifestyle Interventions In Post Liver And Kidney Transplants), which is not on this map. Cited by 56 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Weight Loss and Physical Activity Lifestyle Interventions In Post Liver And Kidney Transplants
Who cites it
56 citing papers in PubMed, 2 syntheses or guidelines pooled it, 126 citations in OpenAlex.
- Changes in left ventricular structure and function associated with renal transplantation: a systematic review and meta-analysis.ESC heart failure · 2021Pooled it
- Effects of exercise training on cardiovascular risk factors in kidney transplant recipients: a systematic review and meta-analysis.Renal failure · 2019Pooled it
- A structured, home-based exercise programme in kidney transplant recipients (ECSERT): A randomised controlled feasibility study.PloS one · 2025Trial
- The Role of Angiopoietins in Cardiovascular Outcomes of Kidney Transplant Recipients: An Ancillary Study from the FAVORIT.American journal of nephrology · 2024Trial
- A Pilot Randomized Controlled Trial Using SystemCHANGE™ Approach to Increase Physical Activity in Older Kidney Transplant Recipients.Progress in transplantation (Aliso Viejo, Calif.) · 2020Trial
- Physical activity and risk of cardiovascular events and all-cause mortality among kidney transplant recipients.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2020Trial
- Artificial Intelligence-Electrocardiography to Predict Incident Atrial Fibrillation and Clinical Outcomes in Kidney Transplant Recipients.Kidney360 · 2026Article
- Plasma asymmetric dimethylarginine and its association with cardiovascular risk factors in Vietnamese patients before and after kidney transplantation, 2018-2022.Frontiers in nephrology · 2026Article
- Review
- Surgical Management of Renal Cell Carcinoma in Transplanted Kidneys-A Narrative Review.Cancers · 2025Review
- Early Steroid Withdrawal in Kidney Transplant Recipients: PRO.Kidney360 · 2025Article
- Immunosuppressive drugs and diet interact to modify the gut microbiota and cardiovascular risk factors, and to trigger diabetes.PloS one · 2025Article
- Risks of cardiovascular disease and cerebrovascular disease following kidney transplantation: A nationwide, population-based cohort study.International journal of medical sciences · 2025Article
- Long-term outcomes in rapamycin on renal allograft function: a 30-year follow-up from a single-center experience.BMC nephrology · 2024Article
- Comparison of depression and suicide between dialysis and kidney transplant recipients in Korea: a nationwide population study.Clinical transplantation and research · 2024Article
- The Importance of the FUT2 rs602662 Polymorphism in the Risk of Cardiovascular Complications in Patients after Kidney Transplantation.International journal of molecular sciences · 2024Article
- The Impact ofJournal of personalized medicine · 2024Article
- Cerebrovascular Disease Hospitalization Rates in End-Stage Kidney Disease Patients with Kidney Transplant and Peripheral Vascular Disease: Analysis Using the National Inpatient Sample (2005-2019).Healthcare (Basel, Switzerland) · 2024Article
- Standardized risk-stratified cardiac assessment and early posttransplant cardiovascular complications in kidney transplant recipients.Frontiers in cardiovascular medicine · 2024Article
- KEeP ACTIVe Club Study: Kidney Transplant Recipients' Experiences of a Physical Activity and Social Interaction Virtual Group.Canadian journal of kidney health and disease · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Kidney transplantation is the gold-standard treatment for many patients with end-stage renal disease. Renal transplant recipients (RTRs) remain at an increased risk of fatal and non-fatal cardiovascular (CV) events compared to the general population, although rates are lower than those patients on maintenance haemodialysis. Death with a functioning graft is most commonly due to cardiovascular disease (CVD) and therefore this remains an important therapeutic target to prevent graft failure. Conventional CV risk factors such as diabetes, hypertension and renal dysfunction remain a major influence on CVD in RTRs. However it is now recognised that the morbidity and mortality from CVD are not entirely accounted for by these traditional risk-factors. Immunosuppression medications exert a deleterious effect on many of these well-recognised contributors to CVD and are known to exacerbate the probability of developing diabetes, graft dysfunction and hypertension which can all lead on to CVD. Non-traditional CV risk factors such as inflammation and anaemia have been strongly linked to increased CV events in RTRs and should be considered alongside those which are classified as conventional. This review summarises what is known about risk-factors for CVD in RTRs and how, through identification of those which are modifiable, outcomes can be improved. The overall CV risk in RTRs is likely to be multifactorial and a complex interaction between the multiple traditional and non-traditional factors; further studies are required to determine how these may be modified to enhance survival and quality of life in this unique population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.